✦ LIBER ✦

PCN13 COST-EFFECTIVENESS ANALYSIS OF DOCETAXEL VERSUS OTHER REGIMENS IN THE ADJUVANT THERAPY OF EARLY AND LOCALLY ADVANCED BREAST CANCER IN POLAND

✍ Scribed by J Walczak; D Pawlik; R Wojcik; M Kaczor; J Lis; G Nogas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN32 COST-UTILITY ANALYSIS OF DOCETAXEL

✍ J Walczak; D Pawlik; R Wojcik; M Kaczor; J Lis; G Nogas 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PCN50 COST-EFFECTIVENESS OF DOCETAXEL PL

✍ S Jones; L Chen; M Tangirala; L Asmar; P Airia; MF Thompson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

PCN38 COST-EFFECTIVENES ANALYSIS OF DOCE

✍ J Walczak; K Lasota; I Malczak; D Pawlik; A Semeniuk; A Simon; M Bryl; J Lis; G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

PCN98 COST-EFFECTIVENESS OF ADJUVANT THE

✍ D Grecea; S Baculea; PC Radu; B Pana; M Szkultecka-Debek 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PCN12 IMPACT OF ADJUVANT CHEMOTHERAPY WI

✍ H Miadi-Fargier; C Le Pen; MC Woronoff-Lemsi; JP Guastalla; X Pivot; H Roché; F 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PCN7 COST-EFFECTIVENESS ANALYSIS OF ADJU

✍ E Orlewska; T Pienkowski; K Drosik; M Gyldmark; R Aultman; M Szkultecka-Debek 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB